Previous studies have demonstrated that RNA-binding proteins (RBPs) were frequently mutated in leukemia patients and essential for leukemia growth and differentiation [14–19], such as RBM17 and RBM39 in AML. This evidence concerns the gene RBM39 and acute myeloid leukemia.